Description
Aging Health Sciences focuses on eye health and marketing nutraceuticals targeting eye diseases, including macular degeneration, glaucoma and others. In the US alone, there are over 15 million people currently diagnosed with AMD and seeking improved treatment options, with another million people being newly diagnosed annually. There is a class of nutraceuticals on the market developed based on the AREDS clinical trial protocols that contain vitamins, several minerals, and lutein. This formulation has been demonstrated in trials to delay AMD progression statistically, but does not prevent the disease. (Ocuvite, PreserVision & generics.)